Brief: Ryvu Therapeutics Q3 Net Loss Widens To 18.3 Mln Zlotys
Nov 29 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* Q3 NET LOSS 18.3 MILLION ZLOTYS VERSUS LOSS OF 11.8
MILLION
ZLOTYS YEAR AGO
* Q3 OPERATING REVENUE 16.2 MILLION ZLOTYS VERSUS 19.7
MILLION
ZLOTYS YEAR AGO
* Q3 OPERATING LOSS 24.3 MILLION ZLOTYS VERSUS LOSS OF 12.9
MILLION ZLOTYS YEAR AGO
Source text for Eikon: ID:nEM6px8Ssa
Further company coverage: RVU.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Q1 Net Loss 12.6 Million Zlotys
Brief: Ryvu Therapeutics Updates Romacyclib Development Strategy
Brief: Ryvu Therapeutics FY Net Loss At 101.2 Mln Zlotys
Brief: Ryvu Therapeutics Extends Research Collaboration And Exclusive License Agreement With BioNTech Until Nov 29, 2028
Brief: Ryvu Therapeutics Signs Grant Agreement With Poland's NCBR For PERO Project